touchSATELLITE SYMPOSIUM for touchNEUROLOGY
Listen to this touchSATELLITE SYMPOSIUM on how to optimize diagnosis and care of patients with Alzheimer’s disease (AD), recorded live in October 2023 at the World Neurology Congress 2023 in Montreal, Canada.
Dr Sharon Cohen (behavioural neurologist from Canada), the chair for the symposium, is joined by Prof. Sven Haller (neuroradiologist from Switzerland) and Dr Ronan Factora (geriatrician from the USA).
The first session (03:40), led by Dr Sharon Cohen, focuses on the importance of an early and accurate diagnosis of AD in the DMT era. This is followed by the discussion of a patient case and audience Q&A (24:23).
In the second session (31:27), Prof. Sven Haller discusses the use of imaging and fluid biomarkers in the diagnostic process for. This is followed by the discussion of a patient case and audience Q&A (42:17).
In the third session (54:10), Dr Ronan Factora offers practical insights on how to achieve collaborative patient-centred care across the AD continuum. This is followed by the discussion of a patient case and audience Q&A (01:08:04).
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Eli Lilly and Company and is jointly provided by USF Health and touchIME.
For further information visit our website
Current and future considerations for the use of immune checkpoint inhibitors in NSCLC
Shaping ART around individual needs: Maximizing adherence and quality of life
Latest developments in neuromyelitis optica spectrum disorder (NMOSD): Diagnostics, treatments and patient-centered care
Latest developments in neuromyelitis optica spectrum disorder (NMOSD): Diagnostics, treatments and patient-centered care
Key considerations for treatment selection and sequencing in patients with RRMM: Lessons from real-life clinical practice
Key considerations for treatment selection and sequencing in patients with RRMM Lessons from real-life clinical practice
Individualizing long-term treatment and care in active MS
MDT perspectives on approaches for the use of immune checkpoint inhibitor therapy in patients with solid tumours
MDT perspectives on the role of biomarkers in informing immune checkpoint inhibitor use across tumour types
MDT perspectives on strategies for identifying and monitoring immune-related adverse events
MDT perspectives on indications for immune checkpoint inhibitors in patients with solid tumours
Adverse event identification and management in locally advanced/metastatic urothelial carcinoma
Experts in infectious diseases discuss the practical considerations for COVID-19 vaccination in the Middle East
Part 1 - Advancing the management of adult solid tumours in 2023, and beyond: Unlocking the potential of radiopharmaceuticals
Part 1 - Advancing the management of adult solid tumours in 2023, and beyond: Unlocking the potential of radiopharmaceuticals
Experts in infectious diseases discuss the practical considerations for COVID-19 vaccination in Africa
Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and management
Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and management
Clinical updates from SGO 2023 on PARP inhibitors in ovarian cancer
Improving outcomes in pulmonary arterial hypertension: A multidisciplinary approach
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Museum of the Missing
Strange by Nature Podcast
Sasquatch Chronicles
Hidden Brain